Innovative Biotech Solutions
We are a biotechnology company dedicated to advancing science and improving lives. With cutting-edge research and a team of talented scientists, we strive to develop innovative solutions to some of the world's most pressing problems. Our mission is to make a positive impact on society through our work, and we are committed to excellence in all that we do. Leveraging proprietary platforms such as AcceTT® (CHO-based high-yield production) and BacSec® (endotoxin-free protein expression in E. coli), the company aims to overcome cost and scalability challenges in biologic manufacturing.
A logo featuring a stylized letter 'A' in blue and green with a modern design.
Oncosimis Biotech Technologies
AcceTT® & BacSec® Technologies
Manufacturing of biopharmaceuticals is subjected to many changes, such as rising volume demands by meeting more stringent safety requirements. These prevailing conditions challenging conventional manufacturing platforms to re-think and re-innovate, which have not adapted sufficiently to address these changes at low cost. Oncosimis' (AcceTT® and BacSec®) technology is designed to meet these demands while keeping the yield biologics at a much higher level compared to current competitors. AcceTT® and BacSec® have established platform technologies at lab scale and would ideally be suited for the development and large-scale manufacturing of a wide range of biologic drugs in both CHO cells and E. coli.